Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5716 AL 5730

Can wearable sensor based measures of gait accurately reflect Parkinson's disease severity? A systematic review and meta-analysis

Youssef H, Sabıroğlu M, Mahmoud Abdel-Rahman S, Hasanin T, Manay M, Gönül MN, Mancini M, Del Din S, Vural A.

Parkinsonism Relat Disord. 2026 Jan;142:108108. doi: 10.1016/j.parkreldis.2025.108108. Epub 2025 Nov 8.

Corrigendum to "An antioxidative injectable chitosan hydrogel based on tannic acid modified dialdehyde polyurethane nano-crosslinker targeting RIPK1 to regulate neuroinflammation for amelioration of Parkinson's disease" [Biomaterials, 325 (2026), 123614]

Xu J, Guo C, Zhou G, Chen H, Dai P, Tang C, Lin SH, Chen TY, Zhang C, Chen F, Dong N, Li C, Pan J, Chen X, Wu P, Li S, Luo L, Li X, Shuai J, Hsu SH, Wang Z.

Biomaterials. 2026 Apr;327:123842. doi: 10.1016/j.biomaterials.2025.123842. Epub 2025 Nov 13.

Letter to the Editor on "Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease"

Bergmans B, Antonini A.

Mov Disord Clin Pract. 2026 Apr;13(4):1113-1114. doi: 10.1002/mdc3.70435. Epub 2025 Nov 15.

Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants

Pokorny R, Ryan JM, Abd-Elaziz K, van den Berg F, Rabiner E, Searle GE, Schneider M, Wiessner C, Stallaert JF, Permanne B, Quattropani A, Beher D.

Mov Disord. 2026 Feb;41(2):436-444. doi: 10.1002/mds.70104. Epub 2025 Nov 15.

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility

Parlar SC, Lee Y, Gan-Or Z.

Mov Disord. 2026 Mar;41(3):761-766. doi: 10.1002/mds.70127. Epub 2025 Nov 15.

Investigating the impact of resveratrol and quercetin on glymphatic function, blood-brain barrier, and neuroglial health: A systematic review

Grandi R, Gulati V, Islam MS, Ekpo O, Chitranshi N.

Brain Res. 2026 Jan 1;1870:150046. doi: 10.1016/j.brainres.2025.150046. Epub 2025 Nov 13.

Relationship between Parkinson's disease and diabetes mellitus: Evidence from the bench to bedside

Peng Y, Lin LX, Wu SL, Kang XH, Jiang DY, Yao SY, Du MQ.

Parkinsonism Relat Disord. 2026 Jan;142:108109. doi: 10.1016/j.parkreldis.2025.108109. Epub 2025 Nov 10.

Zolpidem in Parkinson's disease: An unexpected friend?

Mittal SO, Girigosavi KB.

Parkinsonism Relat Disord. 2026 Jan;142:108113. doi: 10.1016/j.parkreldis.2025.108113. Epub 2025 Nov 12.

Levodopa consumption in sleep: A novel parasomnia in Parkinson's disease

Jha S, Jog MS.

Parkinsonism Relat Disord. 2026 Jan;142:108122. doi: 10.1016/j.parkreldis.2025.108122. Epub 2025 Nov 14.

Letter to the editor: B-type natriuretic peptide in Parkinson's disease: a novel biomarker of dysautonomia

Zhou M, Zhou T.

Parkinsonism Relat Disord. 2026 Jan;142:108123. doi: 10.1016/j.parkreldis.2025.108123. Epub 2025 Nov 12.

Backward walking as a mobility assessment and exercise intervention for persons with neurologic disorders: A scoping review

VanNostrand M, Monaghan PG, Wu W, Fritz NE.

Gait Posture. 2026 Feb;124:110048. doi: 10.1016/j.gaitpost.2025.110048. Epub 2025 Nov 10.

Phenoconsonance: A New Form of Neurological Analysis That Complements Anatomical Localization and Disease Pattern Recognition

Guell X, Schmahmann JD.

J Neuropsychiatry Clin Neurosci. 2026 Spring;38(2):107-119. doi: 10.1176/appi.neuropsych.20250067. Epub 2025 Nov 17.

Drp1 in Parkinson's disease: Mechanisms of disease pathology and the promise of targeted therapeutic strategies

Liu S, Huang Z, Yin Z, Chen L, Ye L, Zhang D, Bai X.

Life Sci. 2026 Jan 1;384:124086. doi: 10.1016/j.lfs.2025.124086. Epub 2025 Nov 15.

A Novel Rapidly Progressive Parkinsonism Phenotype with Ophthalmoplegia Associated with the APP p.D678H Mutation

Liu CY, Chen HY, Lee CY, Hsu JL, Lin CH.

Mov Disord Clin Pract. 2026 Apr;13(4):1080-1084. doi: 10.1002/mdc3.70439. Epub 2025 Nov 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias